Photo-Activated Ferrocene-Iridium(III) Prodrug Induces Immunogenic Cell Death in Melanoma Stem Cells
Journal of Medicinal Chemistry · 24.04.2025 · 68 (8) · 8894-8906
DOI: 10.1021/acs.jmedchem.5c00533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 15.04.2025. Verfasst von Qiaoshan Lie und 6 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, Schoo…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Coordination Complexes, Ferrous Compounds, Immunogenic Cell Death. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Science and Technology Program of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer stem cells (CSCs) are key contributors to tumor resistance, recurrence, and metastasis. Conventional chemotherapy often fails to target and eradicate CSCs, significantly impairing their therapeutic efficacy. Herein, we design and synthesize a photoactivated ferrocene-iridium(III) complex (Ir-3) to achieve immunotherapy against melanoma cells (including stem cells). In short, Ir-3 effectively targets mitochondria and dissociates under light irradiation to produce a cytotoxic Ir(III) photosensitizer and Fe2+ ions. They can generate reactive oxygen species by the Fenton reaction, robustly induce ferroptosis and autophagy, and eventually trigger immunogenic cell death in melanoma cells (including stem cells). Furthermore, under light exposure, Ir-3 effectively inhibits stem cell-related properties and promotes macrophage-mediated phagocytosis of melanoma stem cells. For in vivo studies, Ir-3 is encapsulated in DSPE-PEG 2000 to form tumor-targeting Ir-3@PEG nanoparticles. After photoactivation, Ir-3@PEG can significantly inhibit primary and distant tumors, effectively inhibit the stemness of melanoma stem cells, and induce innate and adaptive immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, School of Chemistry, Guangdong Provincial Key Laboratory of Digestive Cance…
- Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China.
- MOE Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan 400201, P. R. China.
ORCID-Profile: Hui Chao
Förderung
- Science and Technology Program of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Lie, Q., Jiang, H., Lu, X., Chen, Z., Liang, J., Zhang, Y., & Chao, H. (2025). Photo-Activated Ferrocene-Iridium(III) Prodrug Induces Immunogenic Cell Death in Melanoma Stem Cells. Journal of Medicinal Chemistry, 68(8), 8894-8906. https://doi.org/10.1021/acs.jmedchem.5c00533
Vancouver
Lie Q, Jiang H, Lu X, Chen Z, Liang J, Zhang Y, et al. Photo-Activated Ferrocene-Iridium(III) Prodrug Induces Immunogenic Cell Death in Melanoma Stem Cells. Journal of Medicinal Chemistry. 2025;68(8):8894-8906. doi:10.1021/acs.jmedchem.5c00533
BibTeX
@article{Lie2025,
author = {Lie, Qiaoshan and Jiang, Hui and Lu, Xiangwan and Chen, Zhuoli and Liang, Jinzhe and Zhang, Yan and Chao, Hui},
title = {Photo-Activated Ferrocene-Iridium(III) Prodrug Induces Immunogenic Cell Death in Melanoma Stem Cells},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {8},
pages = {8894--8906},
doi = {10.1021/acs.jmedchem.5c00533}
}
EUVIMED